Talk to Sam

+1 917 267 7886

Search inside this page

All regions

Free Market Research Guides to Download

Biopharmaceutical Market Statistics, May 2013

You might be interested in: protein, antibody, enzyme, more »

» Read Business News

1-30 of about 6 500 news
Monoclonal Antibody Innovation Trends in France: Transgene declares its Invesment in ElsaLys Biotech, a New Antibody Firm Created by Former Executives

Monoclonal Antibody Innovation Trends In France: Transgene Declares Its Invesment In Elsalys Biotech, A New Antibody Firm Created By Former Executives

  • Company news
  • 13 hours ago
  • by Business Wire

The Start-up Industry player Will Develop Therapeutic Antibodies against Novel Targets in the Fields of Cancer , Inflammation STRASBOURG, France --(BUSINESS WIRE)-- Regulatory News : Transgene SA ( Euronext Paris : TNG)(Paris:TNG), a biopharmaceutical Industry player that develops targeted immunotherapy products to treat major unmet medi...

  • Industries : Biopharmaceutical
  • Countries : France
Vaccine Trends in The United States, Sweden and Thailand: Researchers develop new oral diarrhea vaccine

Vaccine Trends In The United States, Sweden And Thailand: Researchers Develop New Oral Diarrhea Vaccine

  • Industry news
  • 20 hours ago
  • by Cision

University of Gothenburg Vaccine Research Institute (GUVAX) declares successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of diarrhea in children living in low , middle income regions result in 400 million diarrheal episodes , approximately 300 000 death...

  • Industries : Biopharmaceutical
  • Countries : United States
Enzyme Strategic Alliances: Codexis reports higher First quarter net loss, reaffirms outlook for 2013

Enzyme Strategic Alliances: Codexis Reports Higher First Quarter Net Loss, Reaffirms Outlook For 2013

  • Company news
  • 21 hours ago
  • by Datamonitor

Codexis, incorporated , a developer of engineered enzymes for pharmaceutical, biofuel , chemical production, has reported that net loss for the Q1 ended 2013-03-31 was US Dollars 9.62 million , or US Dollars 0.25 loss per share, compared to a net loss of US Dollars 7.49 million , or US Dollars 0.21 loss per share, for tIndustry player quarter ended March 31, 2012 . The company has reaffirmed its prior outlook for the full ...

  • Industries : Biopharmaceutical
Protein Technology Trends in The United States: World Intellectual Property Organization PUBLISHES PATENT OF THE STATE UNIVERSITY OF NEW JERSEY RUTGERS, THOMAS B. ACTON, STEPHEN ANDERSON, YUANPENG JANET HUANG AND GAETANO MONTELIONE...

Protein Technology Trends In The United States: World Intellectual Property Organization Publishes Patent Of The State University Of New Jersey Rutgers, Thomas B. Acton, Stephen Anderson, Yuanpeng Janet Huang And Gaetano Montelione...

  • Industry news
  • 1 day ago
  • by HT Media

World intellectual property organization publishes patent of the state university of new jersey rutgers, thomas b. Acton , stephen anderson , yuanpeng janet huang , gaetano montelione for "transcript optimized expression enhancement for high-level production of proteins , protein domains" (american inventors) geneva , 2013-05-21 -- Publication no. Wo/2013/071295 was published on may 16 . Title of the invention: "trans...

  • Industries : Biopharmaceutical
  • Countries : United States
Enzyme Innovation Trends in Germany and The United States: BASF strengthens its enzyme technology footprint

Enzyme Innovation Trends In Germany And The United States: Basf Strengthens Its Enzyme Technology Footprint

  • Company news
  • 1 day ago
  • by M2 Communications

ENP Newswire - 20 May 2013 Release date- 16052013 - Ludwigshafen, Germany - With 3 separate transactions, BASF has strengthened its technology footprint in industrial enzymes, 1 of BASF's identified growth fields: BASF has completed the acquisition of Henkel's detergents enzyme technology. Additionally, BASF has entered into a research , license agreement with the global biote...

  • Industries : Biopharmaceutical
  • Countries : Germany
Biopharmaceutical Innovation Trends in The United States and Europe: Opko Updates on First Quarter 2013 Operating and Financial Highlights

Biopharmaceutical Innovation Trends In The United States And Europe: Opko Updates On First Quarter 2013 Operating And Financial Highlights

  • Company news
  • 3 days ago
  • by ProQuest Information & Learning

Opko Health, incorporated , a multi-national biopharmaceutical , diagnostics Industry player, reported operating , financial highlights for the Q1 of 2013. "Consistent with our growth strategy, progress across most business fronts accelerated during the Q1 of 2013," said Phillip Frost , OPKO's Chairman , Chief Executive Officer. "We are pleased with the advances of our operating...

  • Industries : Biopharmaceutical
  • Countries : Russian Federation, United States
Biopharmaceutical Innovation Trends in The United States and Europe: Opko Updates on Q1 2013 Operating and Financial Highlights

Biopharmaceutical Innovation Trends In The United States And Europe: Opko Updates On Q1 2013 Operating And Financial Highlights

  • Company news
  • 3 days ago
  • by ProQuest Information & Learning

Opko Health, incorporated , a multi-national biopharmaceutical , diagnostics Industry player, reported operating , financial highlights for the Q1 of 2013. "Consistent with our growth strategy, progress across most business fronts accelerated during the Q1 of 2013," said Phillip Frost , OPKO's Chairman , Chief Executive Officer. "We are pleased with the advances of our operating...

  • Industries : Biopharmaceutical
  • Countries : Russian Federation, United States
Antibody Innovation Trends in The United Kingdom and Russian Federation: World Intellectual Property Organization PUBLISHES PATENT OF IP SCIENCE FOR

Antibody Innovation Trends In The United Kingdom And Russian Federation: World Intellectual Property Organization Publishes Patent Of Ip Science For "antibody Specific For Trans - Resveratrol And Use Thereof" (russian, British Inventors)

  • Company news
  • 4 days ago
  • by HT Media

GENEVA , 2013-05-18 -- Publication No. WO/2013/068758 was published on May 16 . Title of the invention: "ANTIBODY SPECIFIC FOR TRANS - RESVERATROL , USE THEREOF." Applicants: IP SCIENCE LIMITED (GB). Inventors: Ivan Petyaev (GB) , Valery Tsybezov (RU). as reported by the abstract* posted by the World Intellectual Pro...

  • Industries : Biopharmaceutical
  • Countries : United Kingdom, Russian Federation
Protein Trends in The United States: GMA Technologies Assigned Patent

Protein Trends In The United States: Gma Technologies Assigned Patent

  • Industry news
  • 4 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-18 -- GMA Technologies, Austin, Texas , has been assigned a patent (8,440,184) developed by George Georgiou , Austin, Texas , , Everett Stone , Austin, Texas , for "compositions of engineered human arginases , methods for treating cancer." The abstract of the patent published by the U.S. Patent , Trademark Office s...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical Industry in The United States: Event Brief of First quarter 2013 Regeneron Pharmaceuticals profits Conference Call - Final

Biopharmaceutical Industry In The United States: Event Brief Of First Quarter 2013 Regeneron Pharmaceuticals Profits Conference Call - Final

  • Industry news
  • 4 days ago
  • by CQ Transcriptions LLC

CORPORATE PARTICIPANTS . Michael Aberman - Regeneron Pharmaceuticals incorporated ,VP Strategy & IR . Leonard Schleifer - Regeneron Pharmaceuticals incorporated,Founder, President & CEO . George Yancopoulos - Regeneron Pharmaceuticals incorporated ,Founding Scientist, President - Regeneron Laboratories & Chief Scientific Officer . Robert Terifay - Regeneron Pharmaceuticals incorporated ,SVP, Commercial . Murra...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical Innovation Trends in The United States: Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Biopharmaceutical Innovation Trends In The United States: Genentech And Biogen Idec Have Filed For A Re-hearing Of U.s. Court Of Appeals Decision In The Arzerra Patent Infringement Case

  • Company news
  • 4 days ago
  • by GlobeNewswire

Industry player Announcement Genentech , Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark , 2013-05-17 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced today that Genentech , Biogen Idec have filed for a re-hearing en banc (i.e. before all judges of the court) in the appeal case, where the U.S. Court of Appeals for th...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical Innovation Trends in The United States: Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Biopharmaceutical Innovation Trends In The United States: Genentech And Biogen Idec Have Filed For A Re-hearing Of U.s. Court Of Appeals Decision In The Arzerra Patent Infringement Case

  • Company news
  • 4 days ago
  • by DGAP

Genmab A/S 17.05.2013 12:34 Dissemination of a Adhoc News , transmitted by DGAP - a Industry player of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Industry player Announcement -- Genentech , Biogen Idec have filed for re-hearing in the United States Copenhagen, Denmark ; Ma...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical Innovation Trends in The United States: Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Biopharmaceutical Innovation Trends In The United States: Genentech And Biogen Idec Have Filed For A Re-hearing Of U.s. Court Of Appeals Decision In The Arzerra Patent Infringement Case

  • Company news
  • 4 days ago
  • by OMX

Industry player Announcement -- Genentech , Biogen Idec have filed for re-hearing in the United States Copenhagen, Denmark ; 2013-05-17 ? Genmab A/S (OMX: GEN) announced today that Genentech , Biogen Idec have filed for a re-hearing en banc (i.e. before all judges of the court) in the appeal case, where the U.S. Court of Appeals for the Federal Circuit recently upheld the U.S. D...

  • Industries : Biopharmaceutical
  • Countries : United States
Monoclonal Antibody Key Players in France: The start-up ElsaLys Biotech, a new player in the therapeutic monoclonal antibody arena, declares the 1st round of financing with Transgene and Sofimac Partners

Monoclonal Antibody Key Players In France: The Start-up Elsalys Biotech, A New Player In The Therapeutic Monoclonal Antibody Arena, Declares The 1st Round Of Financing With Transgene And Sofimac Partners

  • Industry news
  • 4 days ago
  • by Business Wire

Spin-off from Transgene R&D, ElsaLys Biotech will develop novel monoclonal antibodies against 1st-in-class targets for the treatment of cancer & inflammatory diseases. Dr Jean-Yves Bonnefoy , former VP, R&D of Transgene is CEO of ElsaLys Biotech , President in office of Alsace BioValley competitiveness cluster. LYON, France & ILLKIRCH-GRA...

  • Industries : Biopharmaceutical
  • Countries : France
Nucleic Acid Innovation Trends in India: Intellectual Property India Publishes Patent Application for 'Regulatory Nucleic Acid Molecules for Enhancing Seed-Specific and/or Seed-Preferential...

Nucleic Acid Innovation Trends In India: Intellectual Property India Publishes Patent Application For 'regulatory Nucleic Acid Molecules For Enhancing Seed-specific And/or Seed-preferential...

  • Company news
  • 5 days ago
  • by HT Media

Intellectual Property India Publishes Patent Application for 'Regulatory Nucleic Acid Molecules for Enhancing Seed-Specific ,/or Seed-Preferential Gene Expression in Plants' Filed by BASF Plant Science MUMBAI, India , May 17 -- Intellectual Property India has published a patent application (2082/CHENP/2012 A) filed by BASF Plant Science Company GmbH , Germany on 2012-03-06 for 'regul...

  • Industries : Biopharmaceutical
  • Countries : India
Protein Trends in The United States: Aphios Assigned Patent

Protein Trends In The United States: Aphios Assigned Patent

  • Industry news
  • 5 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-17 -- Aphios, Woburn, Mass. , has been assigned a patent (8,440,614) developed by Trevor P. Castor , Arlington, Mass. , for "polymer microspheres/nanospheres , encapsulating therapeutic proteins therein." The abstract of the patent published by the ...

  • Industries : Biopharmaceutical
  • Countries : United States
Growth Hormone Trends in The United States: Tercica Assigned Patent

Growth Hormone Trends In The United States: Tercica Assigned Patent

  • Industry news
  • 5 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-17 -- Tercica, South San Francisco, Calif. , has been assigned a patent (8,440,616) developed by Ross G. Clark , Devonport, New Zealand , for "methods for treatment of insulin-like growth factor-1 deficiency." The abstract of the patent published by the U.S. Patent , Trademark Office states: "The present invention provides a ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nucleic Acid Innovation Trends in The United States: World Intellectual Property Organization PUBLISHES PATENT OF EXOSOME DIAGNOSTICS AND JOHAN KARL OLOV SKOG FOR

Nucleic Acid Innovation Trends In The United States: World Intellectual Property Organization Publishes Patent Of Exosome Diagnostics And Johan Karl Olov Skog For "cerebrospinal Fluid Assay" (american Inventor)

  • Company news
  • 5 days ago
  • by HT Media

GENEVA , 2013-05-17 -- Publication No. WO/2013/071239 was published on May 16 . Title of the invention: "CEREBROSPINAL FLUID ASSAY." Applicants: EXOSOME DIAGNOSTICS incorporated (--) , Johan Karl Olov Skog (SE). Inventors: Johan Karl Olov Skog (US). as reported by the abstract* posted by the World Intellectual Property Organization : "The present invent...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical Sector in The United States, China and Brazil: Event Brief of First quarter 2013 Sanofi SA profits Conference Call - Final

Biopharmaceutical Sector In The United States, China And Brazil: Event Brief Of First Quarter 2013 Sanofi Sa Profits Conference Call - Final

  • Industry news
  • 5 days ago
  • by CQ Transcriptions LLC

CORPORATE PARTICIPANTS . Sebastien Martel - Sanofi SA ,VP, IR . Christopher Viehbacher - Sanofi SA ,CEO . Hanspeter Spek - Sanofi SA ,President, Global Operations . Jerome Contamine - Sanofi SA ,EVP, CFO CONFERENCE CALL PARTICIPANTS . Mark Dainty - Citigroup,Analyst . Vincent Meunier - Exane BNP Paribas,Analyst . Richard Vosser - JPMorgan,Analyst . Peter Verdul...

  • Industries : Biopharmaceutical
  • Countries : United States, China
Biopharmaceutical and Sport Nutritional Innovation Trends in The United States: Researchers Submit Patent Application,

Biopharmaceutical And Sport Nutritional Innovation Trends In The United States: Researchers Submit Patent Application, "methods Of Identifying Hsp90 Inhibitors With Less Ocular Toxicity", For Approval

  • Company news
  • 5 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Politics & Government Week -- From Washington, D.C. , VerticalNews journalists report that a patent application by the inventors Zhou, Dan ( Lexington, MA ); Inoue , Takayo ( Malden, MA ), filed on October 26, 2012 , was made available online on 2013-05-09 . The patent's assignee for patent application serial number 662048 is Synta Pharmaceutica...

  • Industries : Biopharmaceutical, Sport Nutritional
  • Countries : United States
Sport Nutritional and Biopharmaceutical Innovation Trends in Japan: New Findings from National Food Research Institute Update Understanding of Carbohydrate Research

Sport Nutritional And Biopharmaceutical Innovation Trends In Japan: New Findings From National Food Research Institute Update Understanding Of Carbohydrate Research

  • Company news
  • 5 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Science Letter -- Investigators publish new report on Carbohydrate Research . as reported by news reporting originating from Ibaraki, Japan , by NewsRx editors, the research stated, "A gene of inulin fructotransferase (DFA III-producing) [EC 2.4.1.93] from Arthrobacter sp. L68-1 was cloned , the nucleotide was sequenced." Our news editors obtained a...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Japan
Antibody Innovation Trends: Ambrx collaborates with Bristol-Myers to develop antibody drug conjugates

Antibody Innovation Trends: Ambrx Collaborates With Bristol-myers To Develop Antibody Drug Conjugates

  • Company news
  • 5 days ago
  • by Datamonitor

Ambrx incorporated , a biopharmaceutical Industry player, has entered into a collaboration agreement with Bristol-Myers Squibb for the discovery , development of novel antibody drug conjugates using Ambrx's protein medicinal chemistry technology. Under terms of the agreement, Ambrx will receive an upfront payment of US Dollars 15 million , funding for discovery , research activitie...

  • Industries : Biopharmaceutical
  • Countries : World
Protein Industry Overview in The United States and Germany: Germany-Influence of Streptococcal virulence factors on host autophagy regulation Project

Protein Industry Overview In The United States And Germany: Germany-influence Of Streptococcal Virulence Factors On Host Autophagy Regulation Project

  • Industry news
  • 6 days ago
  • by Al Bawaba Ltd.

Start date:May 01, 2013 End date:2015-04-30 Duration:24 months Project Reference:329520 Project cost: 168794 EURO ( 217153.48 US Dollar ) Project Funding: 168794 EURO ( 217153.48 US Dollar ) Programme Acronym: FP7-PEOPLE Programme type:Seventh Framework Programme Subprogramme region:Marie-Curie Action: "Intra-European fellowships for career development" Contract type:Intra-Europ...

  • Industries : Biopharmaceutical
  • Countries : United States, Germany
Protein Market Overview in The United States and Germany: Germany-Influence of Streptococcal virulence factors on host autophagy regulation Project

Protein Market Overview In The United States And Germany: Germany-influence Of Streptococcal Virulence Factors On Host Autophagy Regulation Project

  • Industry news
  • 6 days ago
  • by Al Bawaba Ltd.

Start date:May 01, 2013 End date:2015-04-30 Duration:24 months Project Reference:329520 Project cost: 168794 EURO ( 217153.48 US Dollar ) Project Funding: 168794 EURO ( 217153.48 US Dollar ) Programme Acronym: FP7-PEOPLE Programme type:Seventh Framework Programme Subprogramme region:Marie-Curie Action: "Intra-European fellowships for career development" Contract type:Intra-Europ...

  • Industries : Biopharmaceutical
  • Countries : United States, Germany
Biopharmaceutical Trends in Canada: Nordion Signs Contract Manufacturing Agreement with Navidea Biopharmaceuticals

Biopharmaceutical Trends In Canada: Nordion Signs Contract Manufacturing Agreement With Navidea Biopharmaceuticals

  • Industry news
  • 6 days ago
  • by Business Wire

OTTAWA, Ontario --(BUSINESS WIRE)-- Nordion incorporated (TSX: NDN) (NYSE: NDZ), a leading provider of products , services to the global health science Industry, today announced it has signed a contract manufacturing agreement with Navidea Biopharmaceuticals , a biopharmaceutical Industry player focused on precision diagnostic radiopharmaceuticals. Under t...

  • Industries : Biopharmaceutical
  • Countries : Canada
Biopharmaceutical Innovation in Jordan and The United States: Recent Research from Applied Science University Highlight Findings in Carboxylic Ester Hydrolases

Biopharmaceutical Innovation In Jordan And The United States: Recent Research From Applied Science University Highlight Findings In Carboxylic Ester Hydrolases

  • Industry news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Gastroenterology Week -- Data detailed on Enzymes , Coenzymes have been presented. as reported by news reporting originating in Amman, Jordan , by NewsRx journalists, research stated, "Berberine (BBR) , dihydroberberine (HBBR) were investigated as inhibitors of pancreatic lipase in an attempt to explore their potential hypolipidemic activities. The s...

  • Industries : Biopharmaceutical
  • Countries : Jordan, United States
Protein Innovation Trends in China and The United States: Researchers from Jiangnan University Report Details of New Studies and Findings in the Area of Bacillus subtilis

Protein Innovation Trends In China And The United States: Researchers From Jiangnan University Report Details Of New Studies And Findings In The Area Of Bacillus Subtilis

  • Company news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Proteomics Weekly -- Researchers detail new data in Gram-Positive Bacteria. as reported by news reporting out of Wuxi , People's Republic of China , by NewsRx editors, research stated, "In this study, a naturally unsecretory intrinsically disordered domain of nucleoskeletal-like protein (Nsp) was attempted to be secreted with different types of secret...

  • Industries : Biopharmaceutical, Sport Nutritional
  • Countries : China, United States
Protein Innovation in The United States and Oceania: Researchers from University of Auckland Describe Findings in Tuberculosis

Protein Innovation In The United States And Oceania: Researchers From University Of Auckland Describe Findings In Tuberculosis

  • Industry news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Tuberculosis Week -- Data detailed on Mycobacterium Infections have been presented. as reported by news reporting out of Auckland, New Zealand , by NewsRx editors, research stated, "Alpha-Isopropylmalate synthase (alpha-IPMS) is a multi-domain protein catalysing the condensation of alpha-ketoisovalerate (alpha-KIV) , acetyl coenzyme A (AcCoA) to form a...

  • Industries : Biopharmaceutical
  • Countries : New Zealand, United States, Oceania
Protein Market Position in The United States: University of California Reports Findings in Cellular Molecular Biology

Protein Market Position In The United States: University Of California Reports Findings In Cellular Molecular Biology

  • Company news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on Cellular Molecular Biology have been published. as reported by news originating from La Jolla, California , by NewsRx correspondents, research stated, "Diaphanous homologue 1 (DIAPH1) is a Rho effector protein that coordinates cellular dynamics by regulating microfilament , microtubule function. We prev...

  • Industries : Biopharmaceutical, Sport Nutritional
  • Countries : United States
Protein Technology Trends in Pakistan: Researchers from University of Karachi Report Recent Findings in Aquaculture

Protein Technology Trends In Pakistan: Researchers From University Of Karachi Report Recent Findings In Aquaculture

  • Industry news
  • 6 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Life Science Weekly -- Research findings on Aquaculture are discussed in a new report. as reported by news reporting out of Karachi, Pakistan , by NewsRx editors, research stated, "The effects of several dietary protein levels on the growth, feed conversion, body composition , diet digestibility of juvenile Lutjanus argentimaculatus (body weight 12.3...

  • Industries : Biopharmaceutical, Sport Nutritional
  • Countries : Pakistan

Reportlinker.com © Copyright 2013. All rights reserved.

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.